Cargando…
Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar
BACKGROUND AND AIM: The availability of direct‐acting antiviral (DAA) treatment and point‐of‐care diagnostic testing has made hepatitis C (HCV) elimination possible even in low‐ and middle‐income countries (LMICs); however, testing and treatment costs remain a barrier. We estimated the cost and cost...
Autores principales: | Win, Thin Mar, Draper, Bridget Louise, Palmer, Anna, Htay, Hla, Sein, Yi Yi, Shilton, Sonjelle, Kyi, Khin Pyone, Hellard, Margaret, Scott, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684991/ https://www.ncbi.nlm.nih.gov/pubmed/38034058 http://dx.doi.org/10.1002/jgh3.12978 |
Ejemplares similares
-
Outcomes of the CT2 study: A ‘one‐stop‐shop’ for community‐based hepatitis C testing and treatment in Yangon, Myanmar
por: Draper, Bridget Louise, et al.
Publicado: (2021) -
Decentralized, Community-Based Hepatitis C Point-of-Care Testing and Direct-Acting Antiviral Treatment for People Who Inject Drugs and the General Population in Myanmar: Protocol for a Feasibility Study
por: Draper, Bridget Louise, et al.
Publicado: (2020) -
Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
por: Scott, Nick, et al.
Publicado: (2021) -
Feasibility of decentralised, task-shifted hepatitis C testing and treatment services in urban Myanmar: implications for scale-up
por: Draper, Bridget Louise, et al.
Publicado: (2022) -
Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study
por: Yee, Win Lei, et al.
Publicado: (2022)